These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4726791)

  • 1. [Symposium II. Immunosuppressive therapy in rheumatoid arthritis. 3. Pathologic effects of immunosuppressive agents and their adverse anti-inflammatory effects].
    Kyogoku M; Watanabe S; Sagino H; Obu R; Shimomura R
    Ryumachi; 1973 Jan; 13(1):38-47. PubMed ID: 4726791
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current possibilities in the antiphlogistic and immunosuppressive therapy of progressive chronic polyarthritis].
    Tanner E; Klotz L; Seidel K
    Beitr Rheumatol; 1971; 16():143-72. PubMed ID: 4946260
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic approach to elderly patients with rheumatoid arthritis].
    Beccerica E
    Clin Ter; 1987 Aug; 122(4):289-98. PubMed ID: 2973390
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical therapy of rheumatoid arthritis in the adult (critical review)].
    Baldi E; Bonora N
    G Clin Med; 1985; 66(5-6):175-86. PubMed ID: 3934025
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dosage and adverse effects of commonly used antirheumatic agents].
    Mathies H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):320-6. PubMed ID: 5317064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early chronic polyarthritis. Possibilities and limits of inhibition of joint destruction].
    Wollenhaupt J; Zeidler H
    Internist (Berl); 1993 Apr; 34(4):307-15. PubMed ID: 8486474
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of rheumatoid arthritis with immunosuppressive agents].
    Inzoli MR; Almici C
    Minerva Med; 1973 Aug; 64(57):2987-91. PubMed ID: 4742637
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and therapy of rheumatoid arthritis].
    Azuma I
    Arerugi; 1993 Dec; 42(12):1749-53. PubMed ID: 8110035
    [No Abstract]   [Full Text] [Related]  

  • 11. Keeping up on arthritis meds.
    Hennig LM; Burrows SK
    RN; 1986 Feb; 49(2):32-8. PubMed ID: 3633127
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive therapy in rheumatoid arthritis.
    Rainer F
    Acta Med Austriaca; 1988; 15(5):137-40. PubMed ID: 3064524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis and therapeutics of iatrogenic consequences, produced by treatment of rheumatoid arthritis (author's transl)].
    Vanslype J; Tritsmans E; Verstraete J
    Acta Rhumatol Belg; 1978; 2(1-2):22-33. PubMed ID: 751468
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival and death in rheumatoid arthritis.
    Cosh JA
    J Rheumatol; 1984 Apr; 11(2):117-9. PubMed ID: 6726710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symposium II. 4-2. Effects of various anti-inflammatory and immunosuppressive agents on renal and other lesions of New Zealand mice (NZB-WF1)].
    Abe C; Shiokawa Y
    Ryumachi; 1973 Jan; 13(1):50-2. PubMed ID: 4726793
    [No Abstract]   [Full Text] [Related]  

  • 16. [Symposium II. 4-1. Long-term immunosuppressive therapy for rheumatoid arthritis].
    Kobayashi I; Imura S
    Ryumachi; 1973 Jan; 13(1):48-9. PubMed ID: 4726792
    [No Abstract]   [Full Text] [Related]  

  • 17. [New approaches to the basic therapy of rheumatoid arthritis].
    Sigidin IaA; Murav'ev IuV; Zhukovskaia GN; Akparov VKh
    Ter Arkh; 1990; 62(5):8-12. PubMed ID: 2204143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined immunosuppressive-antiphlogistic therapy of chronic rheumatic diseases].
    Tanner E; Siering H; Keil K
    Arzneimittelforschung; 1970 Nov; 20(11):1804-6. PubMed ID: 5536997
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with immunosuppressives in arthritis rheumatoid].
    Cetina Manzanilla JA
    Prensa Med Mex; 1977; 42(1-2):96-9. PubMed ID: 896653
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphocyte subpopulations in patients with rheumatoid arthritis after anti-inflammatory and immunosuppressive treatment].
    Drozd C
    Reumatologia; 1983; 21(1):33-7. PubMed ID: 6606203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.